Bioactive Plant-Derived Compounds as Novel Perspectives in Oral Cancer Alternative Therapy
Pharmaceuticals · 24.07.2025 · 18 (8) · 1098
DOI: 10.3390/ph18081098 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 24.07.2025. Verfasst von Gabriela Mitea und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Ovidius University of Constanta, 900470 Constanta, Romania. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 266 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Oral squamous cell carcinoma (OSCC) is one of the most serious forms of cancer in the world. The opportunities to decrease the mortality rate would lie in the possibility of earlier identification of this pathology, and at the same time, the immediate approach of anticancer therapy. Furthermore, new treatment strategies for OSCC are needed to improve existing therapeutic options. Bioactive compounds found in medicinal plants could be used to support these strategies. It is already known that they have an increased potential for action and a safety profile; therefore, they could improve the therapeutic effect of classical chemotherapeutic agents in combination therapies. Methodology: This research was based on an extensive review of recently published studies in scientific databases (PubMed, Scopus, and Web of Science). The selection criteria were based on experimental protocols investigating molecular mechanisms, synergistic actions with conventional anticancer agents, and novel formulation possibilities (e.g., nanoemulsions and mucoadhesive films) for the targeted delivery of bioactive compounds in OSCC. Particular attention was given to in vitro, in vivo, translational, and clinical studies that have proven therapeutic relevance.
Results
Recent discoveries regarding the effect of bioactive compounds in the treatment of oral cancer were analyzed, with a view to integrating them into oncological practice for increasing therapeutic efficacy and reducing the occurrence of adverse reactions and treatment resistance.
Conclusions
Significant progress has been achieved in this review, allowing us to appreciate that the valorization of these bioactive compounds is emerging.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Pharmacy, Ovidius University of Constanta, 900470 Constanta, Romania.
- Department of Cellular and Molecular Biology, Faculty of Pharmacy, Ovidius University of Constanta, 900470 Constanta, Romania.
- Department of Toxicology, Faculty of Pharmacy, Ovidius University of Constanta, 900470 Constanta, Romania.
ORCID-Profile: Gabriela Mitea, Verginica Schröder, Irina Mihaela Iancu
Zitieren
APA
Mitea, G., Schröder, V., & Iancu, I. M. (2025). Bioactive Plant-Derived Compounds as Novel Perspectives in Oral Cancer Alternative Therapy. Pharmaceuticals, 18(8), 1098. https://doi.org/10.3390/ph18081098
Vancouver
Mitea G, Schröder V, Iancu IM. Bioactive Plant-Derived Compounds as Novel Perspectives in Oral Cancer Alternative Therapy. Pharmaceuticals. 2025;18(8):1098. doi:10.3390/ph18081098
BibTeX
@article{Mitea2025,
author = {Mitea, Gabriela and Schröder, Verginica and Iancu, Irina Mihaela},
title = {Bioactive Plant-Derived Compounds as Novel Perspectives in Oral Cancer Alternative Therapy},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {8},
pages = {1098},
doi = {10.3390/ph18081098}
}
EUVIMED